Toggle light / dark theme

New strategy may target common cancer driver with minimal side effects

Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.